Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.

Slični predmeti

• PASD1 is a potential multiple myeloma-associated antigen.
  od: Sahota, S, i dr.
  Izdano: (2006)
• PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
  od: Cooper, C, i dr.
  Izdano: (2006)
• Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
  od: Ait-Tahar, K, i dr.
  Izdano: (2009)
• Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
  od: Ait-Tahar, K, i dr.
  Izdano: (2009)
• DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
  od: Joseph-Pietras, D, i dr.
  Izdano: (2010)